INTERNATIONAL PATENT: CEMM - FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH, ST. ANNA KINDERKREBSFORSCHUNG GMBH FILES APPLICATION FOR "ANTIBODY CONJUGATED CHEMICAL INDUCERS OF DEGRADATION OF RBM39 AND THERAPEUTIC USES THEREOF"

GENEVA, Feb. 2 -- CEMM - FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH (Lazarettgasse 14AKH BT 25.31090 Wien), ST. ANNA KINDERKREBSFORSCHUNG GMBH (Zimmermannplatz 101090 Wien) filed a patent application (PCT/EP2025/071565) for "ANTIBODY CONJUGATED CHEMICAL INDUCERS OF DEGRADATION OF RBM39 AND THERAPEUTIC USES THEREOF" on Jul 25, 2025. With publication no. WO/2026/022395, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KONC, Juraj (c/o CeMM - Forschungszentrum fur Molekulare Medizin GmbHLazarettgasse 14 / AKH BT 25.31090 W...